Postoperative hypertension

Orthopedics

Volumn 27, Issue 11, 2004, Pages 1159-1161

  Weant, Kyle A ^a,b   Flynn, Jeremy D ^a   Smith, Kelly M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b Dept of Pharmacy ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CLONIDINE; ESMOLOL; FENOLDOPAM; HYDRALAZINE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ARTICLE; BLOOD PRESSURE REGULATION; CYANIDE POISONING; DISEASE SEVERITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAXIMUM PERMISSIBLE DOSE; ORTHOPEDIC SURGERY; PLASMA RENIN ACTIVITY; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; VASCULAR RESISTANCE;

EID: 9244260601     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/0147-7447-20041101-11     Document Type: Article

References (20)

1. Hogenson KD. Acute postoperative hypertension in the hypertensive patient. J Post Anesth Nurs. 1992; 7:38-44.
2. Towne JB, Bernhard VM. The relationship of postoperative hypertension to complications following carotid endarterectomy. Surgery. 1980; 88:575-580.
3. Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med. 1992; 20:1637-1643.
4. Gal TJ, Cooperman LH. Hypertension in the immediate postoperative period. Br J Anaesth. 1975; 47:70-74.
5. Bove EL, Fry WJ, Gross WS, Stanley JC. Hypotension and hypertension as consequences of baroreceptor dysfunction following carotid endarterectomy. Surgery. 1979; 85:633-637.
6. Wallach R, Karp RB, Reves JG, Oparil S, Smith LR, James TN. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. Am J Cardiol. 1980; 46:559-565.
7. Goldberg ME, Larijani GE. Perioperative hypertension. Pharmacotherapy. 1998; 18:911-914.
8. Oates JA, Brown NJ. Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York, NY. McGraw-Hill; 2001:871-900.
9. Gray RJ, Bateman TM, Czer LS, Conklin C, Matloff JM. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension. Am J Cardiol. 1987; 59:887-891.
10. Goldberg ME, Seltzer JL, Azad SS, Smullens SN, Marr AT, Larijani GE. Intravenous labetalol for the treatment of hypertension after carotid endarterectmy. J Cardiothorac Vasc Anesth. 1989; 3:411-417.
11. Berowitz NL. Antihypertensive agents. In: Katzung BG, ed. Basic and Clinical Pharmacology. 7th ed. Hartford, CT: Appleton & Lange; 1998:153-178.
12. Abdelwahap W, Frishman W, Landan A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol. 1995; 35:747-762.
13. IV Nicardipine Study Group. Efficacy and safety of intravenous nicardipine in control of postoperative hypertension. Chest. 1991; 99:393-398.
14. Singh BN, Josephson MA. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. Am Heart J. 1990; 119:427-434.
15. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996; 276:1328-1331.
16. Geniton DJ. A comparison of the hemodynamic effects of labetalol and sodium nitroprus-side in patients undergoing carotid endarterectomy. AANA J. 1990; 58:281-287.
17. Francis GS. Vasodilators in the intensive care unit. Am Heart J. 1991: 121(6 Pt 1):1875-1878.
18. Patel CB, Laboy V, Venus B, Mathru M, Wier D. Use of sodium nitroprusside in post-coronary bypass surgery. A plea for conservatism. Chest. 1986; 89:663-667.
19. Hill AJ, Feneck RO, Walesby RK. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery. J Cardiothorac Vasc Anesth. 1993; 7:279-284.
20. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000; 118:214-227.